Please login to the form below
NICE
This page shows the latest NICE news and features for those working in and with pharma, biotech and healthcare.
Eli Lilly’s Verzenios recommended by NICE as combination therapy for early-stage breast cancer
Eli Lilly’s Verzenios (abemaciclib) has been recommended by the National Institute for Health and Care Excellence (NICE) as a treatment for early-stage breast cancer in combination with endocrine therapy. ... The NICE approval of Verzenios in
Latest news
-
Shionogi Europe and NHS England agree on antibiotic subscription model
The deal comes after the National Institute for Health and Care Excellence’s (NICE) draft guidance recommending Fetcroja, issued in April 2022, for the treatment of severe multidrug-resistant aerobic ... exist. Fetcroja is one of two antimicrobial
-
NICE recommends Vazkepa for patients at risk of stroke and heart attacks in England and Wales
Amarin’s Vazkepa (icosapent ethyl) has been recommended by the National Institute for Health and Care Excellence (NICE) for adults receiving statin treatment who are deemed to be at high cardiovascular ... Vazkepa is a new active substance, made up of
-
UK government allocates up to £680m a year to two funds offering cutting-edge treatments
for Health and Care Excellence (NICE), that balances the weights of cost versus the benefit of drugs used by the NHS. ... The treatment would be made available to patients in need while data is assessed by NICE to determine whether the medicine is
-
NICE recommends Sanofi and Regeneron’s Libtayo for advanced CSCC
NICE’s decision was based on positive results from the EMPOWER-CSCC-1 trial. ... NICE first recommended that Libtayo should be made available through the Cancer Drugs Fund (CDF) in 2019.
-
Almirall and Inserm Transfert to develop innovative vitiligo treatments
The collaboration agreement, signed by Inserm Transfert on behalf of Inserm, Centre Hospitalier Universitaire of Nice and University of Nice Côte d’Azur, aims to identify and develop a novel class
More from news
Approximately 420 fully matching, plus 838 partially matching documents found.
Latest Intelligence
-
A creative awakening – how pharma is bringing innovation to the patient journey
Creativity is more than just nice pictures and some nice words.
-
Health technology assessments: understanding the global landscape and considerations for drug development
The National Institute for Health and Care Excellence (NICE) in the UK has long used cost- effectiveness assessments as the centre of its HTA, price and reimbursement process.
-
Mapping patient pathways with a focus on patient-centricity: the role of medical education
You only need look at the National Institute for Health and Care Excellence (NICE) pathways in adult Type 2 Diabetes (T2D) to see how many specialists are involved, including the diabetologist,
-
The power of the patient influencer
They may be advocating for their fellow patients behind the scenes, lobbying NICE for access to medicines, or publicising fundraising efforts via their local media.
-
How early-stage clinical research is facilitating the new wave of personalised medicines
For example, the UK health technology appraiser, NICE, is undergoing a review of its methodology to ensure that it can be more flexible in evaluating complex innovations such as personalised medicines.
More from intelligence
Approximately 12 fully matching, plus 134 partially matching documents found.
Latest appointments
-
NICE looks internally for new chief executive
He was appointed in April 1999 when NICE was first established under Tony Blair’s ‘New Labour’ government. ... I am delighted that Gill has been appointed as NICE’s next chief executive.
-
Professor Carole Longson moves from NICE to the ABPI
The Association of the British Pharmaceutical Industry (ABPI) has attracted Professor Carole Longson away from the National Institute for Health and Care Excellence (NICE) to be its new chief scientific officer, ... She most recently spent the 18 years
-
New health ministers and re-appointments after reshuffle
Freeman's role is also tied into the Department for Business, Innovation and Skills and includes expanded responsibility for the Cancer Drugs Fund, NICE and MHRA, research and development, issues around
-
Virgo Health Education appoints new senior team
She has over 15 years' experience working in medical education and is a member of the ISMPP Ethics Committee, the NICE Implementation External Reference Group and part of the Royal Berkshire
-
Former NICE chair Sir Michael Rawlins to lead MHRA
Care Excellence (NICE) from its formation in 1999 to his departure last year.
More from appointments
Approximately 4 fully matching, plus 10 partially matching documents found.
Latest from PMHub
-
Could femtech be the answer to the gender health gap?
37. While the app is approved for sale in the UK and can be advertised to the public, NICE still argues that there is not yet sufficient evidence for the app ... Published September 10, 2018. Accessed November 4, 2021. Wilkinson E. NICE: More evidence
-
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current ‘avoidance’ approach to allergies and how this impacts
-
Top 10 Tips for “Virtualizing” In-person Meetings
While Pharma was already slowly pivoting towards virtual events as a substitute for, or supplement to, in-person meetings, COVID-19 quickly changed virtual events from a nice-to-have to
-
What do NHS changes and the Life Sciences Vision mean for medicines?
expensive treatment (even going outside of NICE guidance) because of this prioritised aspect of product value.
-
Abbie's (associate copywriter) first 6-months at COUCH Health
Yet, it’s so nice that I’ve not felt disconnected from the company at all, considering most of my interaction with the team has been online.
More from PMHub
Approximately 2 fully matching, plus 57 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- Biogen and Happify Health team up to create digital platform for MS patients
- Moderna to launch Innovation and Technology Center in the UK
- Enanta takes legal action against Pfizer over Paxlovid patent infringement
- Novartis and Precision BioSciences announce in vivo gene editing collaboration
- A creative awakening – how pharma is bringing innovation to the patient journey
- How Resonant’s innovation and creativity resolve healthcare communications challenges
- The pharma dichotomy
- Our Top 5 Pharma Picks From Cannes Lions
- Live Webinar: Streamlining the Drug Development Process to Transform Global Health
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- NHS App to revolutionise digital health and care with major digital updates by 2023
- ALL SYSTEMS GO: UNDERSTANDING WHO’S WHO IN THE NEW NHS LANDSCAPE
- A creative awakening – how pharma is bringing innovation to the patient journey
- AstraZeneca’s Evusheld phase 3 results show high level of protection against COVID-19
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- Novartis endorses Kigali Declaration by investing $250m for tropical diseases
- Pfizer, Mylan move ahead with generics merger and spin-out
PMHub
Oxford PharmaGenesis
Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups....
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
